Concepedia

Joachim R. Goethert

JR

Statistics

Publications

1

Citations

11

H-Index

1

Active since

2023

Affiliations

Middlemore Clinical Trials(Current)

Joachim R. Goethert is an author at Middlemore Clinical Trials specializing in immunopharmacotherapy, systemic treatments, and myeloproliferative neoplasm therapy.

Publications per year

2023–2023

1

Publications

1

Bomedemstat (IMG-7289), an LSD1 Inhibitor, Manages the Signs and Symptoms of Essential Thrombocythemia (ET) While Reducing the Burden of Cells Homozygous for Driver Mutations

Joachim R. Goethert, Harinder Gill, Francesca Palandri et al. · Blood · 2023 · 11 citations · Full text

, , +10

1–1 of 1